Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.

BACK TO LIST

Patient
Name:	Bobrowicz, Angelika
DOB:	26-AUG-1952 (Age: 73)
Gender:	female
Address:	al. Przemysłowa 137 32-050 Skawina (Poland)
ID:	5772-615752-2 (ECI)

Report
Date:	03-AUG-2018

Laboratory
dr Ample, Ex Laboratoire Central Européenne Boulevard du Jardin Botanique 32 1000 Brussels (Belgium)

Requested by
Krakowskie Centrum Rehabilitacji 30-233 Kraków (Poland)

Specimen
Collected:	03-AUG-2018

Chemistry

Test	03-AUG-2018	Reference Range	Unit
Hemoglobin A1c/Hemoglobin.total in Blood	6.3 H	4.0 - 5.6	%
Glucose [Mass/volume] in Blood	71.8	70 - 100	mg/dL
Urea nitrogen [Mass/volume] in Blood	10.2	7 - 20	mg/dL
Creatinine [Mass/volume] in Blood	0.5 L	0.6 - 1.3	mg/dL
Calcium [Mass/volume] in Blood	9.3	8.5 - 10.5	mg/dL
Sodium [Moles/volume] in Blood	141.5	135 - 145	mmol/L
Potassium [Moles/volume] in Blood	4.4	3.5 - 5.1	mmol/L
Chloride [Moles/volume] in Blood	106.3	98 - 107	mmol/L
Carbon dioxide, total [Moles/volume] in Blood	26.9	22 - 29	mmol/L
Cholesterol [Mass/volume] in Serum or Plasma	278.4 H	125 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	135.7	0 - 149	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	193.7 H	0 - 100	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	57.5	40 - 60	mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows elevated HbA1c, indicating impaired glucose control or possible diabetes, and significantly high total and LDL cholesterol, suggesting increased cardiovascular risk. Creatinine is slightly below normal but not clinically concerning. Other parameters, including glucose, renal function (urea), electrolytes, calcium, triglycerides, and HDL cholesterol, are within normal limits. Recommend further evaluation and management of glycemic control and dyslipidemia.

Conclusion and Recommendations based on this report and previous findings known to us

The patient shows elevated HbA1c, indicating impaired glucose control or possible diabetes, and significantly high total and LDL cholesterol, suggesting increased cardiovascular risk. Creatinine is slightly below normal but not clinically concerning. Other parameters, including glucose, renal function (urea), electrolytes, calcium, triglycerides, and HDL cholesterol, are within normal limits. Recommend further evaluation and management of glycemic control and dyslipidemia.